Downregulation of NIT2 inhibits colon cancer cell proliferation and induces cell cycle arrest through the caspase-3 and PARP pathways

Zheng,Bo'an; Chai,Rui; Yu,Xiaojun

doi:10.3892/ijmm.2015.2125

Downregulation of NIT2 inhibits colon cancer cell proliferation and induces cell cycle arrest through the caspase-3 and PARP pathways

Authors:
- Bo'an Zheng
- Rui Chai
- Xiaojun Yu
View Affiliations

Affiliations: Department of Colorectal Surgery, Zhejiang Provincial People's Hospital, Hangzhou, Zhejiang 310014, P.R. China, Department of Gastroenterological Surgery, Zhejiang Provincial People's Hospital, Hangzhou, Zhejiang 310014, P.R. China
Published online on: March 4, 2015 https://doi.org/10.3892/ijmm.2015.2125
Pages: 1317-1322

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Colorectal cancer, also known as colon cancer is the most devastating malignancy worldwide. Previous studies have reported that Nit2, a member of the nitrilase superfamily, is a potential tumor suppressor, although its function remains elusive in colon cancer. In the present study, we employed an RNA interference lentivirus system to silence endogenous NIT2 expression in the colon cancer cell line, HCT116. The knockdown efficiency was determined by RT-qPCR and western blot analysis. The depletion of NIT2 markedly inhibited colon cancer cell proliferation and colony formation and induced cell cycle arrest in the G0/G1 phase, as shown by MTT assay, colony fromation assay and flow cytometric analysis, respectively. Further investigation with an intracellular signaling array demonstrated that the depletion of NIT2 triggered the apoptosis of colon cancer cells through the caspase-3 and poly(ADP-ribose) polymerase (PARP) pathways. Our findings suggest that NIT2 may be an oncogene in human colon cancer and may thus serve as a promising therapeutic target for the treatment of colon cancer.

View Figures

View References

1	Merika E, Saif MW, Katz A, Syrigos K and Morse M: Colon cancer vaccines: an update (Review). In Vivo. 24:607–628. 2010.PubMed/NCBI
2	Jemal A, Siegel R, Ward E, Hao Y, Xu J and Thun MJ: Cancer statistics, 2009. CA Cancer J Clin. 59:225–249. 2009. View Article : Google Scholar : PubMed/NCBI
3	Cunningham D, Atkin W, Lenz HJ, et al: Colorectal cancer. Lancet. 375:1030–1047. 2010. View Article : Google Scholar : PubMed/NCBI
4	Fearon ER: Molecular genetics of colorectal cancer. Annu Rev Pathol. 6:479–507. 2011. View Article : Google Scholar
5	Bartling D, Seedorf M, Mithofer A and Weiler EW: Cloning and expression of an Arabidopsis nitrilase which can convert indole-3-acetonitrile to the plant hormone, indole-3-acetic acid. Eur J Biochem. 205:417–424. 1992. View Article : Google Scholar : PubMed/NCBI
6	Pace HC and Brenner C: The nitrilase superfamily: classification, structure and function. Genome Biol. 2:REVIEWS00012001. View Article : Google Scholar : PubMed/NCBI
7	Horst RJ, Zeh C, Saur A, Sonnewald S, Sonnewald U and Voll LM: The Ustilago maydis Nit2 homolog regulates nitrogen utilization and is required for efficient induction of filamentous growth. Eukaryot Cell. 11:368–380. 2012. View Article : Google Scholar : PubMed/NCBI
8	Pace HC, Hodawadekar SC, Draganescu A, et al: Crystal structure of the worm NitFhit Rosetta Stone protein reveals a Nit tetramer binding two Fhit dimers. Curr Biol. 10:907–917. 2000. View Article : Google Scholar : PubMed/NCBI
9	Pekarsky Y, Campiglio M, Siprashvili Z, et al: Nitrilase and Fhit homologs are encoded as fusion proteins in Drosophila melanogaster and Caenorhabditis elegans. Proc Natl Acad Sci USA. 95:8744–8749. 1998. View Article : Google Scholar : PubMed/NCBI
10	Barglow KT, Saikatendu KS, Bracey MH, et al: Functional proteomic and structural insights into molecular recognition in the nitrilase family enzymes. Biochemistry. 47:13514–13523. 2008. View Article : Google Scholar : PubMed/NCBI
11	Lin CH, Chung MY, Chen WB and Chien CH: Growth inhibitory effect of the human NIT2 gene and its allelic imbalance in cancers. FEBS J. 274:2946–2956. 2007. View Article : Google Scholar : PubMed/NCBI
12	Kim DH, Behlke MA, Rose SD, Chang MS, Choi S and Rossi JJ: Synthetic dsRNA Dicer substrates enhance RNAi potency and efficacy. Nat Biotechnol. 23:222–226. 2005. View Article : Google Scholar
13	Guo W, Zhang Y, Chen T, et al: Efficacy of RNAi targeting of pyruvate kinase M2 combined with cisplatin in a lung cancer model. J Cancer Res Clin Oncol. 137:65–72. 2011. View Article : Google Scholar
14	Yang H, He X, Zheng Y, et al: Down-regulation of asparagine synthetase induces cell cycle arrest and inhibits cell proliferation of breast cancer. Chem Biol Drug Des. 84:578–584. 2014. View Article : Google Scholar : PubMed/NCBI
15	Shao X, Liu Y, Huang H, Zhuang L, Luo T and Ge X: Down-regulation of G protein-coupled receptor 137 by RNA interference inhibits cell growth of two hepatoma cell lines. Cell Biol Int. Dec 9–2014.Epub ahead of print. PubMed/NCBI
16	Miyake M, Goodison S, Urquidi V, Gomes Giacoia E and Rosser CJ: Expression of CXCL1 in human endothelial cells induces angiogenesis through the CXCR2 receptor and the ERK1/2 and EGF pathways. Lab Invest. 93:768–778. 2013. View Article : Google Scholar : PubMed/NCBI
17	Boatright KM and Salvesen GS: Mechanisms of caspase activation. Curr Opin Cell Biol. 15:725–731. 2003. View Article : Google Scholar : PubMed/NCBI
18	Shi Y: Caspase activation: revisiting the induced proximity model. Cell. 117:855–858. 2004. View Article : Google Scholar : PubMed/NCBI
19	Kurokawa M and Kornbluth S: Caspases and kinases in a death grip. Cell. 138:838–854. 2009. View Article : Google Scholar : PubMed/NCBI
20	Brognard J and Hunter T: Protein kinase signaling networks in cancer. Curr Opin Genet Dev. 21:4–11. 2011. View Article : Google Scholar :
21	Isabelle M, Moreel X, Gagne JP, et al: Investigation of PARP-1, PARP-2, and PARG interactomes by affinity-purification mass spectrometry. Proteome Sci. 8:222010. View Article : Google Scholar : PubMed/NCBI
22	Piskunova TS, Yurova MN, Ovsyannikov AI, et al: Deficiency in poly(ADP-ribose) polymerase-1 (PARP-1) accelerates aging and spontaneous carcinogenesis in mice. Curr Gerontol Geriatr Res. 7541902008.PubMed/NCBI
23	Yu SW, Andrabi SA, Wang H, et al: Apoptosis-inducing factor mediates poly(ADP-ribose) (PAR) polymer-induced cell death. Proc Natl Acad Sci USA. 103:18314–18319. 2006. View Article : Google Scholar : PubMed/NCBI
24	Parcellier A, Schmitt E, Gurbuxani S, et al: HSP27 is a ubiquitin-binding protein involved in I-kappaBalpha proteasomal degradation. Mol Cell Biol. 23:5790–5802. 2003. View Article : Google Scholar : PubMed/NCBI
25	Meister A and Otani TT: ω-Amide and ω-amino acid derivatives of alpha-ketoglutaric and oxalacetic acids. J Biol Chem. 224:137–148. 1957.PubMed/NCBI
26	Meister A, Levintow L, Greenfield RE and Abendschein PA: Hydrolysis and transfer reactions catalyzed by omega-amidase preparations. J Biol Chem. 215:441–460. 1955.PubMed/NCBI
27	Meister A: Preparation of enzymatic reactions of the keto analogues of asparagine and glutamine. J Biol Chem. 200:571–589. 1953.PubMed/NCBI
28	Krasnikov BF, Chien CH, Nostramo R, et al: Identification of the putative tumor suppressor Nit2 as omega-amidase, an enzyme metabolically linked to glutamine and asparagine transamination. Biochimie. 91:1072–1080. 2009. View Article : Google Scholar : PubMed/NCBI
29	Jaisson S, Veiga-da-Cunha M and Van Schaftingen E: Molecular identification of omega-amidase, the enzyme that is functionally coupled with glutamine transaminases, as the putative tumor suppressor Nit2. Biochimie. 91:1066–1071. 2009. View Article : Google Scholar : PubMed/NCBI
30	Hersh LB: Rat liver-amidase. Kinetic evidence for an acyl-enzyme intermediate. Biochemistry. 11:2251–2256. 1972. View Article : Google Scholar : PubMed/NCBI
31	Hersh LB: Rat liver omega-amidase. Purification and properties. Biochemistry. 10:2884–2891. 1971. View Article : Google Scholar : PubMed/NCBI
32	Duffy TE, Cooper AJ and Meister A: Identification of alpha-ketoglutaramate in rat liver, kidney, and brain. Relationship to glutamine transaminase and ω-amidase activities. J Biol Chem. 249:7603–7606. 1974.PubMed/NCBI
33	Cooper AJ and Meister A: Isolation and properties of a new glutamine transaminase from rat kidney. J Biol Chem. 249:2554–2561. 1974.PubMed/NCBI
34	Cooper AJ: Asparagine transaminase from rat liver. J Biol Chem. 252:2032–2038. 1977.PubMed/NCBI
35	Kuhara T, Inoue Y, Ohse M, Krasnikov BF and Cooper AJ: Urinary 2-hydroxy-5-oxoproline, the lactam form of α-ketoglutaramate, is markedly increased in urea cycle disorders. Anal Bioanal Chem. 400:1843–1851. 2011. View Article : Google Scholar : PubMed/NCBI
36	Szeliga M and Obara-Michlewska M: Glutamine in neoplastic cells: focus on the expression and roles of glutaminases. Neurochem Int. 55:71–75. 2009. View Article : Google Scholar : PubMed/NCBI
37	Wang JB, Erickson JW, Fuji R, et al: Targeting mitochondrial glutaminase activity inhibits oncogenic transformation. Cancer Cell. 18:207–219. 2010. View Article : Google Scholar : PubMed/NCBI
38	Erickson JW and Cerione RA: Glutaminase: a hot spot for regulation of cancer cell metabolism? Oncotarget. 1:734–740. 2010.
39	Krasnikov BF, Nostramo R, Pinto JT and Cooper AJ: Assay and purification of omega-amidase/Nit2, a ubiquitously expressed putative tumor suppressor, that catalyzes the deamidation of the α-keto acid analogues of glutamine and asparagine. Anal Biochem. 391:144–150. 2009. View Article : Google Scholar : PubMed/NCBI
40	Semba S, Han SY, Qin HR, et al: Biological functions of mammalian Nit1, the counterpart of the invertebrate NitFhit Rosetta stone protein, a possible tumor suppressor. J Biol Chem. 281:28244–28253. 2006. View Article : Google Scholar : PubMed/NCBI
41	Cutler SR and Somerville CR: Imaging plant cell death: GFP-Nit1 aggregation marks an early step of wound and herbicide induced cell death. BMC Plant Biol. 5:42005. View Article : Google Scholar : PubMed/NCBI
42	Alnemri ES, Livingston DJ, Nicholson DW, et al: Human ICE/CED-3 protease nomenclature. Cell. 87:1711996. View Article : Google Scholar : PubMed/NCBI
43	Walters J, Pop C, Scott FL, et al: A constitutively active and uninhibitable caspase-3 zymogen efficiently induces apoptosis. Biochem J. 424:335–345. 2009. View Article : Google Scholar : PubMed/NCBI